SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : OCATA THERAPEUTICS
OCAT 8.4700.0%Feb 11 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Savant12/24/2010 2:26:28 AM
   of 134
 
Advanced Cell Technology's Chief Medical Officer Featured on National Radio Show
About Biotech Breakthroughs

LOS ANGELES, CA, Dec 23, 2010 (MARKETWIRE via COMTEX) -- Dr. Robert Lanza, the
Chief Scientific Officer of Advanced Cell Technology (ACTC) was featured and
interviewed as "one of the leading scientists making breakthroughs in his field"
on Explorations in Science with best-selling author and television personality,
Dr. Michio Kaku.

The hour long radio program on science and technology is broadcast each week on
WBAI New York City (99.5 FM), and re-aired on stations across the country. The
segment focused attention to the future of biotech and included a discussion
about Lanza's background including his experiments in the field of animal cloning
as well as a brief discourse about his research involving myoblast stem cell
therapies.

For only the second time in history, the Food and Drug Administration approved
the human trial of a therapy developed from embryonic stem cells when Lanza and
the team at Advanced Cell Technology secured approval for human trials of their
retinal pigment epithelial cells to treat Stargardt's Macular Dystrophy.

Robert Lanza, M.D. is considered one of the leading scientists in the world. He
serves as Advanced Cell Technology's Chief Scientific Officer, and Adjunct
Professor at the Institute for Regenerative Medicine, Wake Forest University
School of Medicine. He has hundreds of publications and inventions, and over two
dozen scientific books, among them: "Principles of Tissue Engineering," which is
recognized as the definitive reference in the field. Others include "One World:
The Health & Survival of the Human Species in the 21st Century" (Foreword by
former President and Nobel laureate Jimmy Carter), and the "Handbook of Stem
Cells" and "Essentials of Stem Cell Biology," which are considered the definitive
references in stem cell research.

He is a former Fulbright Scholar, and studied as a student in the laboratory of
Richard Hynes (MIT), Jonas Salk (The Salk Institute), and Nobel laureates Gerald
Edelman (Rockefeller University) and Rodney Porter (Oxford University). He also
worked closely (and coauthored a series of papers) with the late Harvard
psychologist B.F. Skinner and heart transplant pioneer Christiaan Barnard. Dr.
Lanza received his B.A. and M.D. Degrees from the University of Pennsylvania,
where he was both a University Scholar and Benjamin Franklin Scholar.

Dr. Michio Kaku is a theoretical physicist, best-selling author, and popularizer
of science. He's the co-founder of string field theory (a branch of string
theory), and continues Einstein's search to unite the four fundamental forces of
nature into one unified theory. He is a NY Times Bestseller List author and has
appeared on television (Discovery, BBC, ABC, Science Channel, and CNN to name a
few), written for popular science publications like Discover, Wired, and New
Scientist, been featured in documentaries like Me & Isaac Newton, and hosted many
of his own including BBC's recent series on Time.

Investors interested in hearing a full recording of program may do so at:

biomedreports.com

Biotech investors interested in accessing the news portal's complete database of
clinical trials and upcoming FDA decisions can also access that information at:

biomedreports.com

News developments and live healthcare sector updates are available constantly via
twitter at: twitter.com

About BioMedReports.com

BioMedReports.com is a news portal covering the biomedical news and financial
sector. BioMedReports is not paid or compensated to report the news and
developments of publicly traded companies in the healthcare sector of the
markets.

Media Contacts Only:
Mary Davila
Assistant Editor
BioMedReports.com
e-mail: Email Contact
Tel: +1 323 472 4480
Fax: +1 888 210 3556

SOURCE: BioMedReports
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext